This worldwide exclusive license to Merck KGaA, Darmstadt, Germany for the development and commercialization of Xevinapant ... Mar 03
This year US FDA has approved BAVENCIO for the maintenance treatment of patients with locally advanced or metastatic UC... Dec 12
-Advertisements-